187 related articles for article (PubMed ID: 28722840)
1. [Pharmacoeconomics - Challenges for Health Professionals].
Turčić P; Benković V; Brborović O; Valent A
Acta Med Croatica; 2016 Apr; 70(2):117-23. PubMed ID: 28722840
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
Thwaites R; Townsend RJ
Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
[TBL] [Abstract][Full Text] [Related]
3. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
Hoomans T; van der Roer N; Severens JL; Delwel GO
Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
[TBL] [Abstract][Full Text] [Related]
5. Will lower drug prices jeopardize drug research? A policy fact sheet.
Light DW; Lexchin J
Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
[No Abstract] [Full Text] [Related]
6. [Limitations of pharmacoeconomics from a clinical-pharmacological point of view].
Müller M
Wien Med Wochenschr; 2006 Dec; 156(23-24):619-21. PubMed ID: 17211766
[TBL] [Abstract][Full Text] [Related]
7. Penny and pound wise: pharmacoeconomics from a governmental perspective.
van Oostenbruggen MF; Jansen RB; Mur K; Kooijman H
Pharmacoeconomics; 2005; 23(3):219-26. PubMed ID: 15836004
[TBL] [Abstract][Full Text] [Related]
8. The pharmacoeconomic picture in Saudi Arabia.
Alkhenizan A
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
[TBL] [Abstract][Full Text] [Related]
9. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations.
Reeder CE
Am J Health Syst Pharm; 1995 Oct; 52(19 Suppl 4):S5-8. PubMed ID: 8846244
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacoeconomic analyses--chance or 4th hurdle for innovative drugs].
Krammer H
Wien Med Wochenschr; 2006 Dec; 156(23-24):606-11. PubMed ID: 17211764
[TBL] [Abstract][Full Text] [Related]
11. Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.
Bai G; Sen AP; Anderson GF
Ann Intern Med; 2018 Mar; 168(6):436-437. PubMed ID: 29435565
[No Abstract] [Full Text] [Related]
12. [Health outcomes analysis and its applications].
Carrera-Hueso FJ
Rev Med Univ Navarra; 1997; 41(4):237-44. PubMed ID: 10420964
[TBL] [Abstract][Full Text] [Related]
13. Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.
Hoomans T; Severens JL; van der Roer N; Delwel GO
Pharmacoeconomics; 2012 Mar; 30(3):219-27. PubMed ID: 22074610
[TBL] [Abstract][Full Text] [Related]
14. [Use of pharmacoeconomics analyses to health protection].
Drozd M
Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
[TBL] [Abstract][Full Text] [Related]
15. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
Pavenik N
Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of future costs in health economic analysis publications: current situation and recommendations for the future.
Gros B; Soto Álvarez J; Ángel Casado M
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):465-9. PubMed ID: 25737028
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacoeconomics in contemporary medicine].
Czech M
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy: safety, effectiveness, and economics.
Brandys J
Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
[TBL] [Abstract][Full Text] [Related]
19. Pricing and reimbursement of pharmaceuticals in Belgium.
Annemans L; Crott R; De Clercq H; Huybrechts M; Peys F; Robays H; Steens I; Vanschoubroek K; Winderickx P
Pharmacoeconomics; 1997 Mar; 11(3):203-9. PubMed ID: 10165309
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluations in European reimbursement submission guidelines: current status and comparisons.
Bracco A; Krol M
Expert Rev Pharmacoecon Outcomes Res; 2013 Oct; 13(5):579-95. PubMed ID: 24138645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
